A charity that for over 40 years has been supporting unpaid, family carers across Cambridgeshire - those looking after someone at home with a disability or long-term health condition. The carers we ...

This launch represents the Company’s new in silico tools available to customers and is designed to enhance data generation from its range of predictive in vitro tools – unlocking deeper insights into ...

Immersive virtual rooms enhance global collaboration by offering more natural interactions than traditional video calls. With spatial audio, document sharing, and 3D model manipulation, these ...

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, announces the formation of its ...

The Cambridge Index dropped 51.45 points or 0.2% to close at 25,449.8, as five of the top ten heavy weights posted weekly losses in their share prices.

Dovehouse Court is the first almshouse development in the country to fully conform to Passivhaus standards and has already been recognised with a number of prestigious national awards for its energy ...

John Gourd, CEO of Cambridge Network, added: "In response to our members’ needs, we’ve developed a range of resources to support their sustainable growth, including our learning services. The new ...

THE GUARDTECH GROUP are set to end a buoyant 2025 with three big awards evenings – starting with the London Construction Awards at the end of this month.

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, announces the appointment of Craig ...

Cambridge, 1st September 2025 - Xaar, a global leader in digital inkjet technology, is inviting registered charities to apply for its next official charity partnership. This exciting opportunity is an ...

Brett Gordon, a substantial shareholder of the Company (as defined in the AIM Rules), has agreed to subscribe for 2,693,878 Subscription Shares at the Issue Price. The participation by Brett Gordon in ...

Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis ...